4//SEC Filing
Bassler Bonnie L 4
Accession 0001683607-26-000008
CIK 0000872589other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:03 PM ET
Size
9.0 KB
Accession
0001683607-26-000008
Insider Transaction Report
Form 4
Bassler Bonnie L
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-07$374.12/sh+1,500$561,180→ 3,203 total - Sale
Common Stock
2026-01-07$800.00/sh−1,500$1,200,000→ 1,703 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2026-01-07−1,500→ 2,861 totalExercise: $374.12Exp: 2030-01-02→ Common Stock (1,500 underlying)
Footnotes (3)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 2, 2025.
- [F2]Represents volume-weighted average price of sales of 1,500 shares of Company stock on January 7, 2026 at prices ranging from $800.00 to $800.01. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 7, 2026 at each separate price.
- [F3]On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001683607
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:03 PM ET
- Size
- 9.0 KB